Inventor
MARK P. CHAO
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07KPeptides21%
G01NInvestigating or analysing materials by determining their chemical or physical properties15%
C12NMicroorganisms or enzymes9%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms9%
Y02ATechnologies for adaptation to climate change6%
PatentTitleYear
12,274,746Dosing parameters for CD47 targeting therapies to hematologic malignancies202512,162,939Methods for manipulating phagocytosis mediated by CD47202411,780,918Markers of acute myeloid leukemia stem cells202311,718,670Methods for determining and achieving therapeutically effective doses of anti-CD47 agents in treatment of cancer202311,472,878Methods for determining and achieving therapeutically effective doses of anti-CD47 agents in treatment of cancer202211,377,495Markers of acute myeloid leukemia stem cells202211,141,480Dosing parameters for CD47 targeting therapies to hematologic malignancies2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to UNIV LELAND STANFORD JUNIOR (7)· patent assignee history
2021Patents assigned to FORTY SEVEN INC (1)· patent assignee history
2021–2025Based in US· patent location history
2025Patents assigned to FORTY SEVEN LLC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV LELAND STANFORD JUNIOR | 7 | 2021–2025 |
| FORTY SEVEN INC | 1 | 2021 |
| FORTY SEVEN LLC | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2021–2025 |